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Abstract
Objective: To study the relationship between brain-gut peptides, gastrointestinal hormones and altered motility in a rat
model of repetitive water avoidance stress (WAS), which mimics the irritable bowel syndrome (IBS).
Methods: Male Wistar rats were submitted daily to 1-h of water avoidance stress (WAS) or sham WAS (SWAS) for 10
consecutive days. Plasma hormones were determined using Enzyme Immunoassay Kits. Proximal colonic smooth muscle
(PCSM) contractions were studied in an organ bath system. PCSM cells were isolated by enzymatic digestion and IKv and
IBKca were recorded by the patch-clamp technique.
Results: The number of fecal pellets during 1 h of acute restraint stress and the plasma hormones levels of substance P (SP),
thyrotropin-releasing hormone (TRH), motilin (MTL), and cholecystokinin (CCK) in WAS rats were significantly increased
compared with SWAS rats, whereas vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP) and
corticotropin releasing hormone (CRH) in WAS rats were not significantly changed and peptide YY (PYY) in WAS rats was
significantly decreased. Likewise, the amplitudes of spontaneous contractions of PCSM in WAS rats were significantly
increased comparing with SWAS rats. The plasma of WAS rats (100 ml) decreased the amplitude of spontaneous contractions
of controls. The IKv and IBKCa of PCSMs were significantly decreased in WAS rats compared with SWAS rats and the plasma
of WAS rats (100 ml) increased the amplitude of IKv and IBKCa in normal rats.
Conclusion: These results suggest that WAS leads to changes of plasma hormones levels and to disordered myogenic
colonic motility in the short term, but that the colon rapidly establishes a new equilibrium to maintain the normal baseline
functioning.
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Introduction
The irritable bowel syndrome (IBS) is defined as a chronic and
recurrent functional bowel disorder characterized by chronic
abdominal pain, discomfort, bloating, and altered bowel habits in
the absence of any detectable structural abnormalities or infection
on routine testing [1,2]. Altered visceral perception and motility
are the main pathophysiologic factors of IBS [3–6].
Many studies have shown that IBS patients have various
gastrointestinal (GI) motor disturbances that often arise from an
exaggerated physiological response to stimuli such as diet and
stress [7,8]. The stress changes their bowel patterns and produces
abdominal pain [9]. There is now compelling evidence for the
modulatory role of physical and psychological stresses in the
digestive disorders, whether acute or chronic [7]. In particular,
epidemiological, empirical and clinical observations provide
valuable support for life stress as a common co-morbid event in
IBS, which may strongly influence symptom onset, severity, and
persistence in certain IBS subtypes [10,11]. The importance of
psychological factors was underscored by a recent study that
demonstrated significant relief with an open-label placebo given
with the strong suggestion that placebos ‘‘produce significant
mind-body self-healing processes.’’ [12]. Furthermore, IBS
patients tend to be more vulnerable to stressful events in daily
life [13]. They may also have an increased incidence of other
functional, somatoform disorders, as demonstrated by an
increased incidence of ‘‘prostatitis syndrome’’ (PS) or IBS in
patients who have one or the other disorder [14].
It has been shown that stress causes changes in the secretion of
brain-gut peptides and gastrointestinal hormones such as cortico-
tropin releasing hormone (CRH), thyrotropin (TSH), motilin
(MTL), vasoactive intestinal peptide (VIP), and so on [15,16].
Brain-gut peptides are produced by gut endocrine cells, which are
derived from neuroectoderm and can be grouped according to
common cytochemical characteristics, such as the concept of the
acronym APUD (amine precursor uptake and decarboxylation)
[15]. Likewise, the gastrointestinal hormones constitute a group of
hormones secreted by enteroendocrine cells in the stomach,
pancreas, and small intestine that control various functions of the
digestive organs. Enteroendocrine cells do not form endocrine
glands but are scattered throughout the digestive tract. They exert
autocrine and paracrine actions that integrate some of the
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hormones play a role in mediating stress-induced changes in
gastrointestinal motor function [18,19] and colonic permeability
[20,21] as well as rectal sensitivity [22,23]. Furthermore, evidence
in patients with IBS suggests that some peptides and/or hormones
play a significant role in mediating stress-induced alterations of
gastrointestinal motor function [10,24,25].
For the terminal effect of these peptides and hormones on
motor function, permeability and sensitivity, either directly or
indirectly, ion channels play an important role, such as in
controlling the manner and extent of colonic motility [26]. The
main types of K
+ channels associated with motility of the colon
are the Kv and BKca channels, which include trans-membrane
proteins that form the tunnels for the ions and regulatory sub-
units. Peptides and hormones affect these sub-units directly or
indirectly to control the K
+ currents, so as to govern the motility
of the circular smooth muscle (CM) and longitudinal smooth
muscle (LM). The strength of contractions generated by LM and
CM layers are largely determined by the amplitude, duration and
frequency of action potentials, which mediate the rapid influx of
Ca
2+ into smooth muscle cells and the subsequent activation of
the contractile machinery. Potassium (K
+) channels actively
participate in shaping the electrical activity of smooth muscle to
generate outward currents [27]. The opening of K
+ channels is
associated with restoration of the resting potential and inhibition
of contractile activity. The diversity in the types of K
+ channels
found in smooth muscle of the gut reflects the capacity of this
system to fine tune the electrical activity of the syncytium to
control intestinal rhythm. This syncytium is formed by smooth
muscle cells connected to each other both anatomically and
electrically through gap junctions which allow current to flow
intercellularly from one cell to the other, thus enabling the
mechanical activity of the constituent smooth muscle cells to be
coordinated [27]. The high conductances of BK channels provide
ideal negative feedback regulators in many cell types by
decreasing voltage-dependent Ca
2+ entry through membrane
potential hyperpolarization. These channels were first studied in
smooth muscle cells where they are the key players in setting
contractile tone [28].
However, the mechanism through which stress contributes to
colonic motility in IBS patients remains elusive. The repetitive
water avoidance stress (WAS) model stimulates the desire to
survive as well as fear of the surrounding environment. It imposes
the stress of being forced to adapt, mimics the pattern of daily
stress experienced by humans, and is a well-accepted animal
model for studying the possible mechanisms involved in altered
colonic motility [16].
Therefore, our hypothesis was that compared with controls,
WAS rats would have some changes of fecal output in different
environments and alterations in the secretion of peptides and
hormones and in the function of the smooth muscle of the colon,
aside from any pathological changes.
Materials and Methods
Animals
Adult male Wistar rats (200–250 g) were purchased from the
disease control center of Hubei Province. Animals were main-
tained on a normal light-dark cycle, housed in pairs, and provided
with food and water ad libitum. All protocols were approved by
the Institutional Animal Care and Use Committee of Wuhan
University (Approval ID: WHU20110312) and adhered to the
ethical guidelines of the International Association for the Study of
Pain.
Water avoidance stress protocol
As previously described [29], rats were placed on a block
(106868 cm) affixed to the center of a plexiglas cage
(45625625 cm), filled with fresh room temperature water
(25uC) to within 1 cm of the top of the block (WAS) or kept
empty (sham WAS), for 1 h daily, for 10 consecutive days.
Measurement of fecal pellet output and rat weight
We used a validated procedure to estimate autonomic
regulation of distal colonic motility during the WAS [30,31].
Fecal pellets found in the tank were counted at the end of each 1-h
WAS or sham WAS session. The weight of the rats was measured
every day before exposure to WAS or sham WAS to evaluate
weight change from baseline. To measure the baseline colonic
motility after the 10-day testing period, we put the WAS or sham
WAS rats in stand-alone cages for 1 hour on Day 11, after which
the fecal pellets were counted. Subsequently, the colonic motility
of the rats was studied using the acute stress model as described
previously [32]. All rats were lightly anesthetized with ethyl-ether
on Day 11. The fore shoulders, upper forelimbs, and thoracic
trunk of rats were then wrapped in a confining harness of paper
tape to restrict the body movements of rats, following which the
rats were placed in their home cage for 1 h after which the fecal
pellets were counted.
ELISA assay
Rats were anesthetized with ether. The blood from the heart
was collected in EDTA (ethylenediamine tetra-acetic acid) tubes
and spun for 10 min at 3000 rpm. Plasma was pipetted out and
stored under 280uC for further gastrointestinal hormone analysis.
Brain-gut peptides and gastrointestinal hormones were determined
using an Enzyme Immunoassay Kit (R&D, Inc., MI, U.S.A) at a
dose of 10 mL plasma per sample per well for the assay according
to the manufacturer’s instructions. Samples were analyzed in
duplicate in a single assay.
Preparation of isolated colonic smooth muscle strips
Rats were anesthetized with ether, followed by sacrifice along the
ventral midline. The proximal colon was removed, cleaned and
opened along the mesenteric border and then placed in Ca
2+-free
physiological saline solution (PSS) (in mol/L): NaCl 147.0, KCl 4.0,
CaCl2 2.0, NaH2PO4 0.42, Na2HPO4 2.0, MgCl2 1.05, and glucose
5.5 (adjusted to pH 7.4 with NaOH) bubbled with carbogen (95%
O2/5% CO2). The digestive solution contained 0.1% (w/v)
collagenase II, 0.1% (w/v) trypsin inhibitor and 0.2% (w/v) bovine
serum albumin (BSA) dissolved in Ca
2+-free PSS. The internal
pipette solution used in experiments investigating APs and RPs
contained (in mmol/L): K-aspartate 120.0, HEPES 10.0, EGTA
10.0, Na2ATP 5.0, MgCl2 4.0, and CaCl2 3.0 (adjusted to pH 7.4
with KOH). The internal pipette solution of the large conductance
potassium channel contained (in mmol/L): KCl 20.0, K-aspartate
110.0,MgCl2?6H2O 1.0, Mg-ATP5.0, Na2 creatine phosphate2.5,
EGTA 2.5, and 2.0 mg/mL nystatin (adjusted to pH 7.4 with
KOH). The smooth muscle strips (3 mm67 mm) were obtained
after the mucosa and submucosa were excised. When studying
longitudinal smooth muscles (LM), the strips parallel to the
mesenteric were used and when studying circular smooth muscles
(CM), the strips vertical to the mesenteric were used.
Preparation of isolated colonic smooth muscle cells
(SMCs)
Single SMCs were isolated by enzymatic digestion [27]. The
strips of proximal colon were pinned to the base of the Sylgard
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dissected away under an anatomical microscope. The tissue was cut
into small strips (about 2 mm65–6 mm) and placed in Ca
2+-free
PSS solution that contained 0.12% (w/v) collagenase II supple-
mented with 0.2% soybean trypsin inhibitor and 0.2% BSA, and
incubatedfor 19–34 min at 37uC. After completionof digestion, the
segments were washed five times in a Ca
2+-free PSS solution and
then triturated gently with a fire-polished Pasteur pipette to create a
cell suspension. Cells were stored at 0–4uC and used within 8 h.
Contraction recording of proximal colonic smooth
muscle (PCSM) strips
Each fresh smooth muscle strip was mounted in an organ bath
and connected to an isometric force transducer (JZJOIH,
Chengdu, China). The organ baths contained 6 mL Tyrode’s
buffer at 37uC and were constantly warmed by a circulating water
jacket at 37uC and bubbled with carbogen (95% O2/5% CO2).
One end of the strip was fixed to a hook on the bottom of the
chamber, while the other end was connected by a thread to an
external isometric force transducer at the top. Each muscle strip
was placed under a resting preload of 1.0 g to obtain a maximum
response to 1 M ACh and allowed to equilibrate for 60 min.
During the equilibration period, the sections were washed every
20 min with Tyrode’s and the basal tension was maintained. To
obtain a stable and acceptable level of sensitivity before the
experimental procedure began, the colonic section was challenged
with 40 mM KCl until reproducible responses were obtained. The
frequencies of contraction were calculated by counting the
contraction waves per 20 minutes. The mean contractile ampli-
tude and frequency of spontaneous contractions were recorded
(WAS and sham WAS values) and compared with the mean
contractile amplitude and frequency when the control strips were
exposed to 100 ml WAS plasma or sham WAS plasma. Heparin
was used as the anti-coagulant in the plasma instead to avoid
possible influence of the electrolytes caused by EDTA. The results
are presented as the changed percentage (changed percenta-
ge=100%6(response value – control value)/control value).
Whole-cell patch-clamp recordings
Several drops of cell suspensions were placed in a recording
chamber that was mounted with an inverted microscope
(Olympus, Japan). After adhering to the coverslip, the cells were
infused with Tyrode’s buffer (3 mL/min). Pipettes were made
using a micropipette puller (P-97; Sutter, USA). Typical pipette
resistances were 3–5 MV. A gigaseal was formed with negative
suction. Capacitance was compensated for and the residual
capacitance current was removed digitally. Whole-cell currents
were recorded with an EPC-10 amplifier (HEKA, Germany).
Acquisition and analysis of data were accomplished by using
PulseFit (HEKA Instrument, Germany). The internal (pipette)
solution for recording IK (V) contained (in mM) 125 KCl, 4
MgCl2, 10 HEPES, 10 EGTA, and 5 Na2ATP (pH 7.3).The
values of WAS and sham WAS IBKca and IKv currents were
recorded and the effects of WAS plasma or sham WAS plasma at
different concentrations were investigated on IBKca and IKv
when added to control rats. Data were filtered at 200 Hz, digitized
at 10 kHz (filter 1) and 2.9 kHz (filter 2), and stored in the
computer for subsequent analyses. All the experiments were
conducted at 2562uC.
Statistical analysis
All the analyses were carried out using SPSS 13.0 (SPSS Inc.,
Chicago, IL). Data are expressed as mean 6 S.E.M. ‘‘n’’ is the
number of cell analyses isolated from at least five animals.
ANOVA with post hoc Bonferroni’s correction was used for the
comparisons of more than two groups, and Student’s t-test was
used for the comparison of paired samples. P,0.05 was
considered statistically significant.
Results
Comparison of fecal pellet output in WAS rats and SWAS
rats
The fecal pellet output in all animals was significantly increased
by WAS with exposure to the water for 1 hour, and was more for
the first five days (FFD) than for the last five days (LFD)
(6.1460.69 vs. 4.8860.50, p,0.01, Figure 1). However, there was
no such effect with exposure to sham stress (2.4660.67 vs.
2.4260.23, p.0.05, Figure 1). The basal fecal pellet output of the
WAS rats at day eleven showed no significant difference from that
of the SWAS rats (3.160.99 vs. 2.560.84, p=0.164, Figure 1).
When exposed to the acute stress situation, the WAS rats had a
greater fecal pellet output than the SWAS rats (9.561.72 vs.
7.861.68, p,0.05, Figure 1).
Plasma Concentrations of brain-gut peptides
We analyzed the plasma brain-gut peptides and gastrointestinal
hormone levels in the WAS and SWAS rats. As Table 1 shows, the
concentrations of SP, TRH, CCK and MTL were significantly
increased in the WAS rats compared to those in the SWAS rats,
while the concentrations of VIP, CGRP and CRH showed no
significant difference between the two groups. Furthermore, the
plasma levels of PPY in WAS rats were significantly lower than
those in SWAS rats.
WAS increased spontaneous contractile activity of
proximal colonic smooth muscle strips in vitro
The baseline amplitude of spontaneous contractile activities
from the WAS rat colons was significantly increased when
compared to that of the SWAS rats (Figure 2A, 2C). The mean
active tension of longitudinal smooth muscle (LM) in WAS rats
Figure 1. Number of fecal pellets. Number of the fecal pellets in
water avoidance stress (WAS) and sham water avoidance stress (SWAS)
rats at the first five days (FFD) or the last five days (LFD) and at the base
state (BASE) or acute stress state (AS) on the eleventh day. Data are
expressed as mean 6 SEM (n=10). Statistical significance of difference
between fecal pellet counts in WAS and SWAS rats at FFD or LFD and
BASE or AS was evaluated by using unpaired Student’s t-test. **P,0.01,
*P ,0.05 compared between WAS and SWAS.
doi:10.1371/journal.pone.0031774.g001
Plasma Hormones Facilitated the Hypermotility
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31774was significantly higher than that in SWAS rats (1.4160.2 g vs.
1.1260.27 g, P,0.01, Figure 2A, 2B) and the mean active tension
of circular smooth muscle (CM) in WAS rats was significantly
higher than that in SWAS rats (0.4660.11 g vs. 0.3560.07 g,
P,0.05, Figure 2C, 2D). However, the frequency of spontaneous
contractions of CM or LM from WAS rats did not change
significantly (data not shown) when compared to that of SWAS
rats. When tetrodotoxin (TTX, 100 nM) was added into the organ
bath for 30 min to block the influence of the neuronal factors in
the enteric nervous system on smooth muscle contraction, the
spontaneous contractions decreased in the two groups, but the
difference between them still persisted. The frequency of
spontaneous muscle strip contractions was again not significantly
different between the two groups.
WAS plasma decreased spontaneous contractile
amplitude of proximal colonic smooth muscle (PCSM)
strips
The amplitudes of contractile activities of LM and CM with
added WAS rat plasma (WP 100 ul/6 ml) were significantly
decreased (1.0760.29 g vs. 0.8360.31 g and 0.3160.1 g vs.
0.2360.82 g, respectively, p,0.05, Figure 3A–D) in the presence
of 100 nM TTX in the organ bath. However, the amplitude of
contractile activities with added SWAS rat plasma (SWP 100 ul/
6 ml) was not significantly changed (p.0.05). The frequency of
spontaneous contraction activities of CM or LM from WAS rats
was not significantly changed in the absence and presence of WP
or SWP (data not shown here).
Effect of WAS on IKV and IBKca current in PCSMCs
With whole-cell voltage-clamp recordings, a delayed rectifier IK
was found to be the predominant Kv current in freshly isolated rat
PCSMCs (n=28/30). IK was activated slowly at membrane
potentials from positive to 220 mV with no inactivating kinetics
over the stimulation period (600 ms). The transient and fast-
inactivating IA was rare in these cells (2/30). As shown in Figure 4,
the IKv of WAS rats is decreased when compared to that of
SWAS rats (8.0560.86 pA/pF vs. 12.8660.91 pA/pF, p,0.01) at
+60 mv). The large conductance IBKCa current was detected by
using a depolarizing step pulse from a holding potential of
260 mV to +80 mV for 400 ms (Dv=+20 mv). As shown in
Figure 5, the IBKca current density of WAS rats was decreased
Table 1. Plasma brain-gut peptides and gastrointestinal
hormones in WAS and SWAS.
Peptide SWAS WAS
SP 58.2667.97 ng/L 92.44615.76 ng/L*
VIP 52.7263.41 ng/L 48.21364.13 ng/L
TRH 1.0260.25 ulU/ml 2.1260.16 ulU/ml*
CGRP 22.9663.48 ng/L 25.0964.94 ng/L
CRH 18.8660.97 ng/L 19.2960.88 ng/L
MTL 66.5367.49 pg/L 111.6962.41 pg/L**
CCK 75.51619.23 ng/L 153.05625.41 ng/L**
PYY 85.48620.53 ng/L 43.67612.03 ng/L**
*P ,0.05 **P,0.01
doi:10.1371/journal.pone.0031774.t001
Figure 2. WAS increased spontaneous contractile amplitude of proximal colonic smooth muscle (PCSM) strips. A, C: Representative
traces of the effect of WAS or SWAS on the spontaneous contractile amplitude of longitudinal smooth muscle (LM) and circular smooth muscle (CM)
strips. WAS increased the mean contractile amplitude of CM and LM strips in the absence and presence of 100 nm TTX. B, D: Summarized results of
the LM (B) and CM (D) spontaneous contractions in WAS and SWAS rats. Data are expressed as mean 6 SEM (n=12). Significant difference is indicated
by * (P,0.05 compared to SWAS or SWAS-TTX groups, respectively, according to the unpaired Student’s t-test).
doi:10.1371/journal.pone.0031774.g002
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Representative traces of the effect of WAS rat plasma (WP) or SWAS rat plasma (SWP) on the spontaneous contractile amplitude of longitudinal
smooth muscle (LM) and circular smooth muscle (CM) strips. WP decreased the mean contractile amplitude of CM and LM strips in the presence of
100 nm TTX. B, D: Summarized results showing the effect of WP or SWP on LM (B) and CM (D) spontaneous contractions in normal rats. Data are
expressed as mean 6 SEM (n=8). Significant difference is indicated by * (P,0.05 compared to normal (Nor) or Nor-SWP group according to the
ANOVA analysis).
doi:10.1371/journal.pone.0031774.g003
Figure 4. WAS reduced the whole-cell IKv of PCSMC. A: Current tracings elicited by +20 mV depolarizing steps from a constant holding
potential of 280 mV to +60 mv; the basal IKv was reduced in PCSMCs from WAS rats compared with SWAS rats. B: Current-voltage relationships
comparing IKv current density between PCSMCs from WAS and SWAS rats. C: Summarized data showing the density of the currents at 60 mV in WAS
and SWAS PCSMCs. **: P,0.01 vs. SWAS PCSMCs.
doi:10.1371/journal.pone.0031774.g004
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27.2061.30 pA/pF, p,0.01) at +80 mv.
Effect of WAS rat plasma on IKV and IBKca current in rat
PCSMCs
To explore the effect of plasma on IKV and IBKca current in
proximal colon SMCs, we took the plasma of the WAS or SWAS
rats to perfuse the PCSMCs of normal Wistar rats. As shown
in Figure 6, the plasma of the WAS or SWAS rats activated
the IKv current in freshly isolated normal rat PCSMCs
(from 13.0560.66 pA/pF to 17.1061.27 pA/pF, p,0.01, or to
13.6960.78 pA/pF, respectively) at +60 mv. As shown in Figure 7,
the plasma of the WAS or SWAS rats also activated BKCa current
in freshly isolated control rat proximal colon SMCs (from
27.5561.33 pA/pF to 32.5462.02 pA/pF, p,0.01, or to
28.5961.49 pA/pF, respectively).
Discussion
The WAS rat model is regarded as an acceptable and classical
model of IBS [26], and it has been used to investigate mechanisms
of colonic motility [15]. Yet, the definitive pathogenesis of colonic
motility associated with WAS is not available [26,33,34]. The
present study showed the differences of amplitude and frequency
of spontaneous contraction of proximal colonic strips between
WAS rats and SWAS rat, and the changes of amplitude of IKv
and IBKca currents in proximal colon SMCs in the two groups.
These data support our hypothesis that WAS induces disordered
colonic motility, which is associated with the dys-synchrony of
brain-gut peptides and gastrointestinal hormones and with
enhanced myogenic contraction of the proximal colon.
The WAS decreased the transit times of the proximal colon.
Our results show that the WAS treatment resulted in a
significantly higher number of fecal pellets during the 1 h acute
restraint stress treatment in the WAS rats compared to the SWAS
rats, indicating that WAS rats were over-reactive to the acute
stress. This is consistent with the studies of Mayer EA and Welgan
P [29,35]. Curiously, our results also showed that there was no
significant difference of fecal pellet numbers in WAS rats in the
resting state on Day 11 compared with SWAS rats. Also, the WAS
rats adapted to their chronic stress based on the fecal pellet
numbers and behavioral responses in the first five days compared
to the last five days. These results are consistent with the clinical
observation that IBS patients aren’t intolerant of daily stressful
events but develop irritable or spastic colon under various acute
and more extreme stressors. We presume that the normal fecal
pellet counts in WAS rats on Day 11 after 10 days of chronic stress
occurred because of adaptive functioning, as the brain-gut axis,
autonomic nervous system, gastrointestinal hormones and colon
SMCs came to a new homeostasis. This could be due to central
nervous system reintegration around the chronic stressor, such as
by changing the expression of some proteins [2,36] or by the
association of synapses to guide chronic stress hormone secretion.
This would balance microscopic but critical changes of colon
smooth muscle induced by long-term chronic stress, as the PCSM
is in a dynamic equilibrium and could adapt to mild and non-
ulcerogenic new stresses. Accordingly, we studied representative
brain-gut peptides and gastrointestinal hormones as well as the
motility of proximal colon to explore restrictive relationships
between them.
In our present study, the WAS rats had higher levels of SP,
TRH, MTL and CCK in plasma and lower levels of PYY when
compared with SWAS rats. The effects of each hormone in IBS
patients or animal models have been researched extensively with
controversial results [37–40] focused upon relative or absolute
secretory volume. Because each group or individual experiences
different stressors as well as different cultures, genetic back-
grounds, living habits and so on, they have responded differently
to cope with stress [8]. We must regard secretion of brain-gut
peptides and GI hormones as a whole biological activity of the
organism. The results showed that the WAS rat plasma decreased
the amplitude of proximal colon muscle strips in the presence of
100 nM TTX compared to controls (Figure 3) and increased the
IKv and IBKca current density of proximal colon SMCs (Figures 4,
Figure 5. WAS reduced the whole-cell IBKca of PCSMC. A: Current tracings elicited by +20 mV depolarizing steps from a constant holding
potential of 260 mV to +80 mv; the basal IBKca current was reduced in PCSMCs from WAS rats compared with SWAS rats. B: Current-voltage
relationships comparing IBKca density between PCSMCs from WAS and SWAS rats. C: Summarized data showing the density of the currents at 80 mV
in WAS and SWAS PCSMCs. **: P,0.01 vs. SWAS PCSMCs.
doi:10.1371/journal.pone.0031774.g005
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showed that the abnormal levels of brain-gut peptides and GI
hormones in the plasma of WAS rats have been demonstrated in
control rat preparations to correlate with slow colon transit. But
the myogenic changes in the colons of the rats showed the
opposite results (Figure 2), with the amplitude of spontaneous
contractions increased in the presence of 100 nM TTX or not
and with decreased IKv and IBKca current density after WAS
treatment (Figures 4, 5, and 6), whereas the SWAS rats didn’t
have significant changes; in other words, chronic stress
increased colonic motility in the WAS rats compared to the
SWAS rats.
Figure 6. Excitation of IKv in rat PCSMCs by WAS rat plasma (WP). A: Representative record of IK in the absence and presence of WP or SWP.
B: I–V relationships of IK in the absence and presence of WP or SWP. C: Summarized data showing the density of the currents at 80 mv in WAS and
SWAS PCSMCs. **: P,0.01 vs. SWAS PCSMCs according to the ANOVA analysis.
doi:10.1371/journal.pone.0031774.g006
Figure 7. Excitation of IBKca in rat PCSMCs by WAS rat plasma. A: Representative records of IK in the absence and presence of WP or SWP
(50 ul/2 ml). B: I–V relationships of IBKca in the absence and presence of WP OR SWP. C: Summarized data showing the density of the currents at
80 mV in WAS and SWAS PCSMCs. **: P,0.01 vs. SWAS PCSMCs according to the ANOVA analysis.
doi:10.1371/journal.pone.0031774.g007
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two fundamentally different pathways: acting on neurons in the
myenteric plexus and acting directly on the smooth muscle cells.
These differential effects depend on the density of receptors for
these peptides and hormones that exist in myenteric plexus and
CM or LM [41–44] as well as the subtypes of receptors in the
tissue where the activation occurs and on environmental factors
[20]. These peptides and hormones interact with each other in
vivo, in addition to their different affinities for the receptors, and
also act via endocrine, paracrine and neurocrine pathways [45].
The brain-gut hormones and GI hormones are secreted into
blood, and hence circulate systemically, where they affect function
of other parts of the digestive tract, liver, pancreas, brain and a
variety of other targets. Some of these peptides inhibits ghrelin
secretion and exert opposite effects on hypothalamic neuronal
activity and gastric emptying. The physiological actions of peptides
or hormones involve coupling their respective receptors to G-
proteins that stimulate cAMP/cGMP-mediated signaling cascades
[46]. To summarize, this body of research supports our findings
that gastrointestinal hormones and the brain-gut peptides can
directly interact with their associated receptors in smooth muscle
cells, thus influencing muscle tone.
This study has the following limitations: First, we have not
tested whether the changed GI motility is associated with changes
in the nervous system including the myenteric nerve plexus,
submucosal plexus and rhythm of the interstitial cells of Cajal
(ICC) in addition to the association with peptides and hormones.
This deserves further investigation. Second, we have not studied
the potential links between stress and non-stress induced peptides
and hormones. The reasons that female rats were not selected for
this study was to avoid potential effects of estrogen in motility
modulation.
In summary, we found increased motility of proximal colon
smooth muscle in WAS rats, that plasma of WAS rats inhibited the
contraction of proximal colon in control rats, and that WAS rats
had the same fecal pellet count in the unstressed state but an
increased count in the acute stress state compared with SWAS
rats. We concluded that WAS rats adapted well in the normal state
unless an acute stress event occurred. This prompts us to speculate
that in IBS patients, there may be less need to control the motility
of colon in the normal state and more need to focus on
maintaining that state and avoiding or better managing the
occurrence of acutely stressful events.
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